This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Monika Goetz: Innovator in Oligonucleotide Detection
Introduction
Monika Goetz is a distinguished inventor based in Gerbrunn, Germany. She has made significant contributions to the field of biotechnology, particularly in the detection of pathogenic bacteria. Her innovative work has led to the development of a patented technology that enhances the accuracy of microbial detection.
Latest Patents
Monika Goetz holds a patent for "Oligonucleotides for the detection of Enterobacteriaceae." This invention relates to oligonucleotides that serve as nucleic acid probes or primers for identifying Enterobacteriaceae, especially pathogenic strains like Salmonella sp. The oligonucleotides are derived from the salmolysin-like DNA region and possess specific sequences that facilitate effective detection.
Career Highlights
Monika is associated with Merck Patent Gesellschaft mit beschränkter Haftung, where she applies her expertise in biotechnology. Her work has been pivotal in advancing methods for detecting harmful bacteria, thereby contributing to public health and safety.
Collaborations
Throughout her career, Monika has collaborated with notable colleagues, including Andreas Bubert and Albrecht Ludwig. These partnerships have fostered innovation and have been instrumental in the development of her patented technologies.
Conclusion
Monika Goetz exemplifies the spirit of innovation in biotechnology through her groundbreaking work on oligonucleotides for bacterial detection. Her contributions not only enhance scientific understanding but also improve health outcomes.